分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Soft hydrophilic interfaces boost endothelial selectivity of bioactive peptides for long-term vascular graft patency

Yao Xiong, Yage Hu, Hongxia Pu, Jiaqi Wang, Rifang Luo, Fanjun Zhang, Yunbing Wang

Journal:BIOMATERIALS

IF:12.9

DOI:10.1016/j.biomaterials.2026.124159

PMID:41903310

Published:2026-03-24

research field:心血管植入物生物医学工程再生医学组织工程表面改性

Abstract

The surface modification of bioactive molecules is thought to aid endothelial cell adhesion, which is crucial for achieving rapid endothelialization of vascular grafts and thus ensuring long-term patency. However, conventional hydrophilic coatings possess inherent limitations in resisting nonspecific adsorption, making it difficult to maintain selectivity for endothelial cells in complex blood environments. As a result, the deposition of nonspecific proteins and cells on the surface may trigger neointimal hyperplasia and luminal stenosis, ultimately leading to graft failure. This study proposed a soft hydrophilic coating that combines a low elastic modulus with high hydrophilicity and site-specifically grafted the endothelial cell–selective YIGSR peptide via click chemistry. The coating featured a dual physical-chemical antifouling mechanism. Compared to traditional hard hydrophilic coatings, the soft hydrophilic coating showed improved resistance to protein and non-target cell adhesion (such as fibroblasts, smooth muscle cells, and inflammatory cells) in complex biological environments, while maintaining the selective pro-adhesive function of YIGSR peptides for endothelial cells. By specifically interacting with integrin receptors on the endothelial cell surface, the coating facilitated firm endothelial attachment and upregulated vinculin expression, thereby contributing to the formation of a functional endothelium. Notably, in rat and rabbit in vivo small vascular graft replacement models, this coating significantly promoted rapid and functional endothelialization and ensured long-term patency of the grafts. This study provided a new strategy to address the rapid loss of in vivo bioactivity in existing coatings and offered valuable insights for the design of next-generation cardiovascular implants.

本文使用的Yeasen产品

购物车
客服
转染试用